|
MMRGlobal Receives Fifth Patent Expanding Rights to Control of Online Medical Records
LOS ANGELES, CA, Nov 26, 2012 (MARKETWIRE via COMTEX) --
MMRGlobal, Inc. (OTCBB: MMRF) ("MMR") today announced that its
fifth online medical records patent, U.S. Patent No. 8,321,240, is
being issued from the United States Patent and Trademark Office on
Tuesday, November 27th. As of the issuance, MMR will be the owner of
five U.S. patents pertaining to Personal Health Records and other
eHealth records, along with additional patents in at least 13 other
countries of commercial interest. The newest patent significantly
adds to the Company's growing Health Information Technology ("HIT")
patent portfolio consisting of 360 issued and/or pending claims, many
originating as far back as 2005, while further solidifying MMR's
position in the online medical records market. MMR has already
contacted and offered licenses to more than 1,000 hospitals, group
practices, and EMR and PHR providers in letters, sales presentations
and other public forums. Since the Company began sending notices, it
has reached agreements with EMR vendor(s) and others who provide
health IT products and is in conversations with hospitals, trade
associations and nursing agencies with regard to selling or licensing
of the Company's products and services or eHealth IP.
The Company's patents were designed and created to protect its core
health IT business which includes the MyMedicalRecords PHR and MMRPro
document management and scanning systems for healthcare
professionals. The Company also provides online storage solutions
under the MyEsafeDepositBox brand. MMR is making its proprietary
technology available either by selling its products and services, or
through a reasonable licensing program so as not to deprive
healthcare professionals of the value of the MMR patented products
and services. Company CEO Robert H. Lorsch is the inventor of all the
eHealth patents owned by the Company.
The MMR patent portfolio pertains to communication of health
information from healthcare providers to patients and users of
web-based services for user management of medical records, including
but not limited to Electronic Medical Records and Personal Health
Records. The most recent patent expands existing patent coverage for
communication of health information from healthcare providers to
web-based services through multiple forms of electronic messaging
which are standard in the Company's MyMedicalRecords.com PHR and
MMRPro document management and imaging systems including voice, fax,
email and other messaging services.
The Company has already signed license agreements valued at more than
$30 million, of which more than $10 million has already been
invoiced. According to Lorsch, "Unlike patent trolling firms that
seek to monetize another organization's intellectual property, our
patents cover services we currently offer to customers as part of our
existing products. Our intellectual property is based upon our core
business. We saw the opportunity to invent and protect a universally
applicable Personal Health Record and other eHealth products and
services many years ago when we started building them and took steps
to protect our ideas globally."
About MMRGlobal, Inc.
MMRGlobal, Inc., through its wholly-owned
operating subsidiary, MyMedicalRecords, Inc., provides secure and
easy-to-use online Personal Health Records ("PHRs") and electronic
safe deposit box storage solutions, serving consumers, healthcare
professionals, employers, insurance companies, financial
institutions, and professional organizations and affinity groups. The
MyMedicalRecords PHR enables individuals and families to access their
medical records and other important documents, such as birth
certificates, passports, insurance policies and wills, anytime from
anywhere using the Internet. MyMedicalRecords is built on
proprietary, patented technologies to allow documents, images and
voicemail messages to be transmitted and stored in the system using a
variety of methods, including fax, phone, or file upload without
relying on any specific electronic medical record platform to
populate a user's account. The Company's professional offering,
MMRPro, is designed to give physicians' offices an easy and
cost-effective solution to digitizing paper-based medical records and
sharing them with patients in real time through an integrated patient
portal. MMR is an Independent Software Vendor Partner with Kodak to
deliver an integrated turnkey EMR solution for healthcare
professionals. Through its merger with Favrille, Inc. in January
2009, the Company acquired intellectual property biotech assets that
include anti-CD20 antibodies and data and samples from its
FavId(TM)/Specifid(TM) vaccine clinical trials for the treatment of
B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc.
visit www.mmrglobal.com. View demos and video tutorials of the
Company's products and services at www.mmrtheater.com.
Forward-Looking Statements
All statements in this press release
that are not strictly historical in nature, including, without
limitation, potential intellectual property enforcement actions,
infringement claims, litigation or licenses, future performance,
management's expectations, beliefs, intentions, estimates or
projections, constitute "forward-looking statements." Such
forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the Company's actual
results to be materially different from historical results or from
any results expressed or implied by such forward-looking statements.
Some can be identified by the use of words (and their derivations)
such as "need," "possibility," "potential," "intend," "offer,"
"development," "if," "negotiate," "when," "begun," "believe,"
"achieve," "will," "estimate," "expect," "maintain," "plan," and
"continue," or the negative of these words. Actual outcomes of
intellectual property enforcement actions, infringement claims,
litigation or licensing transactions, results of operations and the
timing of selected events may differ materially from the results
predicted, and any reported results should not be considered as an
indication of future performance. Such statements are necessarily
based on assumptions and estimates and are subject to various risks
and uncertainties, including those relating to the possible
invalidity of the underlying assumptions and estimates and possible
changes or developments in economic, business, industry, market,
legal and regulatory circumstances and conditions and actions taken
or omitted to be taken by third parties, including customers,
suppliers, business partners, potential licensees, competitors and
legislative, judicial and other governmental authorities and
officials. Factors that could cause or contribute to such differences
include, but are not limited to: unexpected outcomes with respect to
intellectual property enforcement actions, claims of intellectual
property infringement and general intellectual property litigation;
our ability to maintain, develop, monetize and protect our patent
portfolio for both the Company's health IT and biotechnology
intellectual property assets in the U.S. and internationally; the
timing of milestone payments in connection with licensing our
intellectual property; our ability to establish and maintain
strategic relationships; changes in our relationships with our
licensees; the risk the Company's products are not adopted or viewed
favorably by the healthcare community and consumer retail market;
business prospects, results of operations or financial condition;
risks related to the current uncertainty and instability in financial
and lending markets, including global economic uncertainties; the
timing and volume of sales and installations; the length of sales
cycles and the installation process; the market's acceptance of new
product and service introductions; competitive product offerings and
promotions; changes in government laws and regulations and future
changes in tax legislation and initiatives in the healthcare
industry; undetected errors in our products; the possibility of
interruption at our data centers; risks related to third party
vendors; risks related to obtaining and integrating third-party
licensed technology; risks related to a security breach by third
parties; risks associated with recruitment and retention of key
personnel; other litigation matters; uncertainties associated with
doing business internationally across borders and territories; and
additional risks discussed in the Company's filings with the
Securities and Exchange Commission. The Company is providing this
information as of the date of this release and, except as required by
applicable law, does not undertake any obligation to update any
forward-looking statements contained in this release as a result of
new information, future events or otherwise.
CONTACT:
Michael Selsman
Public Communications Co.
(310) 922-7033
ms@publiccommunications.biz
SOURCE: MMRGlobal, Inc.
mailto:ms@publiccommunications.biz
[ Back To TMCnet.com's Homepage ]
|